Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

transGlideXT Expandable Introducer

K-Number: K181817 · 2019-03-26

Decision Date2019-03-26
Product CodeDYB
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

transGlideXT Expandable Introducer is the device name listed in this FDA 510(k) record. The listed applicant is Transaortic Medical, Inc.. It received FDA 510(k) clearance on 2019-03-26 under 510(k) number K181817. The device is classified under product code DYB. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the transGlideXT Expandable Introducer?

transGlideXT Expandable Introducer is a medical device that received FDA 510(k) clearance on 2019-03-26. The listed applicant is Transaortic Medical, Inc.. The 510(k) number is K181817.

When did transGlideXT Expandable Introducer receive FDA 510(k) clearance?

transGlideXT Expandable Introducer received FDA 510(k) clearance on 2019-03-26, under 510(k) number K181817.

Who is the listed applicant for transGlideXT Expandable Introducer?

The FDA 510(k) record lists Transaortic Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for transGlideXT Expandable Introducer?

The FDA product code for transGlideXT Expandable Introducer is DYB.

Other records listing Transaortic Medical, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DYB)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.